Trials.ai

trials.ai · San Diego, United States of America

Trials.ai is a software company that provides an AI-driven platform to help life sciences organizations design and optimize clinical trial protocols, aiming to improve patient recruitment, reduce amendments, and accelerate study timelines. Its solution analyzes historical trial data and operational constraints to recommend protocol changes and feasibility improvements for sponsors, CROs, and research teams. The company generates revenue through subscription and service-based licensing of its platform to pharmaceutical, biotech, and clinical research organizations.

  • MLOps & ML Platforms
  • Clinical Trial & Research Software
Revenue
$2.0M
Employees
20
Founded
2016
Headquarters
San Diego, United States of America

What 13 Arbolus experts think of Trials.ai

NPS scores show a strong positive skew: 20% of respondents are promoters (NPS 10), 60% yield scores of 8-9, and none report negative sentiment. Among those with specified renewal intent, 100% express intent to renew; however, notable uncertainty exists among pilot and influencer users. Stickiness is high after one year, with the largest share already in advanced implementation. The overall customer sentiment is buoyed by strong NPS, multi-year stickiness, and high-spend promoter profile.Overall Customer Sentiment: Positive

Who reviewed Trials.ai

Total customers 13 10 current · 3 former
Reviews growth +13 in six months
Seniority of respondents
  • C-Suite 54% (7)
  • Director 31% (4)
  • Manager 15% (2)
Operations Leader Manager NPS 8
Strategy Leader Director NPS 10 Will renew
Other Leader Manager NPS 10

Employer names and spend open once the report publishes.

Tell us when the Trials.ai report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

38 Net Promoter Score, from 13 scored reviews
  • Promoters 5
  • Passives 8
  • Detractors 0

Cumulative NPS by month

+0 over 4 months
  • Jan 8
  • Feb 8
  • Mar 8
  • Apr 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 38 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 2 answers
  • Director 100% 1 answer
  • 10/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Trials.ai

Do you use Trials.ai at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of Trials.ai have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.